Truist Financial Increases Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $22.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target raised by analysts at Truist Financial from $21.00 to $22.00 in a report released on Friday,Benzinga reports. The firm currently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s target price points to a potential upside of 6.69% from the stock’s previous close.

SBRA has been the topic of a number of other reports. Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Cantor Fitzgerald raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Tuesday, February 17th. Citigroup lifted their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Citizens Jmp upped their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.90.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA opened at $20.62 on Friday. The firm has a market cap of $5.20 billion, a price-to-earnings ratio of 32.22, a P/E/G ratio of 1.66 and a beta of 0.64. The firm has a fifty day moving average price of $19.65 and a 200 day moving average price of $19.01. Sabra Healthcare REIT has a fifty-two week low of $15.75 and a fifty-two week high of $21.07. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business’s revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several large investors have recently added to or reduced their stakes in the stock. Focus Partners Wealth lifted its stake in shares of Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock valued at $404,000 after purchasing an additional 2,375 shares during the last quarter. Envestnet Asset Management Inc. increased its position in shares of Sabra Healthcare REIT by 15.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 267,445 shares of the real estate investment trust’s stock valued at $4,932,000 after purchasing an additional 35,981 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Sabra Healthcare REIT by 4.7% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 170,205 shares of the real estate investment trust’s stock valued at $3,139,000 after purchasing an additional 7,687 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its holdings in Sabra Healthcare REIT by 550.2% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 235,422 shares of the real estate investment trust’s stock valued at $4,341,000 after buying an additional 199,212 shares during the period. Finally, Allworth Financial LP raised its holdings in Sabra Healthcare REIT by 105.9% during the 2nd quarter. Allworth Financial LP now owns 5,213 shares of the real estate investment trust’s stock valued at $96,000 after buying an additional 2,681 shares during the period. 99.40% of the stock is owned by institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.